Anti-Inflammatory Potentials of β-Ketoester Derivatives of N-Ary Succinimides: In Vitro, In Vivo, and Molecular Docking Studies

Figure 1

Rationale of the COX-2 inhibitors celecoxib and rofecoxib with our compounds (compound D).